This fifth edition of our Signals digest continues to bring together Ipsos’ latest research on coronavirus, including new POVs, country insights, and the latest from the public opinion tracker.
Ipsos is currently running syndicated COVID-19 impact studies to uncover the true impact of the pandemic in key disease areas. Studies gather the perspectives of treating doctors and patients on key issues such as treatment decision-making, patient management, the patient experience and more.
As we approach the ‘new normal’ we have been working hard to develop solutions to maximize social distancing awareness. Naturally this applies to all locations; retailers, offices, warehouses, public places and transport hubs to name just a few. For many years we have been installing our Occupancy solution however, given the current situation, we have developed this further. The Social Distancing Live Occupancy Solution was designed for essential retailers in mind but now, as we approach life 2 meters apart, this solution is being implemented in office buildings as well as retailers.
As Covid-19 continues to disrupt traditional care norms, major pharma products have an unprecedented opportunity to define new market dynamics and demonstrate population health leadership.
